Literature DB >> 19846564

Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.

Kyle Steenland1, Sarah Tinker, Stephanie Frisbee, Alan Ducatman, Viola Vaccarino.   

Abstract

Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are compounds that do not occur in nature but have been widely used since World War II and persist indefinitely in the environment. They are present in the serum of Americans with median levels of 4 ng/mL and 21 ng/mL, respectively. PFOA has been positively associated with cholesterol in several studies of workers. A cross-sectional study of lipids and PFOA and PFOS was conducted among 46,294 community residents aged 18 years or above, who drank water contaminated with PFOA from a chemical plant in West Virginia. The mean levels of serum PFOA and PFOS in 2005-2006 were 80 ng/mL (median, 27 ng/mL) and 22 ng/mL (median, 20 ng/mL), respectively. All lipid outcomes except high density lipoprotein cholesterol showed significant increasing trends by increasing decile of either compound; high density lipoprotein cholesterol showed no association. The predicted increase in cholesterol from lowest to highest decile for either compound was 11-12 mg/dL. The odds ratios for high cholesterol (>/=240 mg/dL), by increasing quartile of PFOA, were 1.00, 1.21 (95% confidence interval (CI): 1.12, 1.31), 1.33 (95% CI: 1.23, 1.43), and 1.40 (95% CI: 1.29, 1.51) and were similar for PFOS quartiles. Because these data are cross-sectional, causal inference is limited. Nonetheless, the associations between these compounds and lipids raise concerns, given their common presence in the general population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846564     DOI: 10.1093/aje/kwp279

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  92 in total

1.  Polyfluorinated compounds in serum linked to indoor air in office environments.

Authors:  Alicia J Fraser; Thomas F Webster; Deborah J Watkins; Jessica W Nelson; Heather M Stapleton; Antonia M Calafat; Kayoko Kato; Mahiba Shoeib; Verónica M Vieira; Michael D McClean
Journal:  Environ Sci Technol       Date:  2011-12-30       Impact factor: 9.028

2.  Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study.

Authors:  Samantha L Kingsley; Douglas I Walker; Antonia M Calafat; Aimin Chen; George D Papandonatos; Yingying Xu; Dean P Jones; Bruce P Lanphear; Kurt D Pennell; Joseph M Braun
Journal:  Metabolomics       Date:  2019-06-21       Impact factor: 4.290

3.  Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Authors:  L-M L Toms; J Thompson; A Rotander; P Hobson; A M Calafat; K Kato; X Ye; S Broomhall; F Harden; J F Mueller
Journal:  Environ Int       Date:  2014-06-27       Impact factor: 9.621

4.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

5.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

6.  Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.

Authors:  Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate
Journal:  Int J Hyg Environ Health       Date:  2019-08-20       Impact factor: 5.840

7.  Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum.

Authors:  Alicia J Fraser; Thomas F Webster; Deborah J Watkins; Mark J Strynar; Kayoko Kato; Antonia M Calafat; Verónica M Vieira; Michael D McClean
Journal:  Environ Int       Date:  2013-09-14       Impact factor: 9.621

8.  Health Status of Workers Exposed to Perfluorinated Alkylate Substances.

Authors:  Philippe Grandjean
Journal:  J Occup Environ Med       Date:  2018-10       Impact factor: 2.162

9.  Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.

Authors:  Kyle Steenland; Sarah Tinker; Anoop Shankar; Alan Ducatman
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

Review 10.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.